Evidence
Indian J Gastroenterol. 2024 Feb 17. doi: 10.1007/s12664-023-01512-y. Online ahead of print.
NO ABSTRACT
PMID:38367161 | DOI:10.1007/s12664-023-01512-y
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
🌐 90 Days
VR Related Evidence Matrix
- Critical care management of acute liver failure
- Role of serum endotoxin, FGF19, TLR2, TNF-α, IL-12 and IL-10 in NAFLD-associated T2DM pathogenesis: Insights into Th1 bias and protective mechanisms
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Spatial genomics: mapping human steatotic liver disease
- The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD)
- Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
- Preventive hepatology at AIIMS Rishikesh: Delivering comprehensive and integrated care for liver diseases in Northern state of India
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Blood Level of Nitric Oxide Metabolites and Expression of Genes Regulating NO Synthesis in Early Forms of Non-Alcoholic Fatty Liver Disease
- Blood Level of Nitric Oxide Metabolites and Expression of Genes Regulating NO Synthesis in Early Forms of Non-Alcoholic Fatty Liver Disease
- Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury
- Role of prostaglandin E2 and its receptors in chronic liver disease
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
- The gut-liver axis in fatty liver disease: role played by natural products
- Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective
- COVID-19 in Individuals with Chronic Liver Diseases
- Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
- Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Changes in the etiology of liver cirrhosis and the corresponding management strategies
- The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
- The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study
- Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An…
- Managing the Patient with Psoriasis and Metabolic Comorbidities
- The double roles of T cell-mediated immune response in the progression of MASLD
- Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets
- Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
- Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study
- Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study
- Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights
- Nonalcoholic Fatty Liver Disease and Ethnicity: Lessons Learned from the Arab Population in Israel
- Metallofullerenol alleviates alcoholic liver damage via ROS clearance under static magnetic and electric fields
- From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
- Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls
- Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- Patients with Celiac Disease Have High Prevalence of Fatty Liver and Metabolic Syndrome
- LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA
- Hospital admissions for chronic liver diseases: a temporal study in the South Region of Brazil
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Natural compounds proposed for the management of non-alcoholic fatty liver disease
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Non-Alcoholic Fatty Liver Disease May Be a Risk Factor for Liver Metastasis After Radical Surgery for Colorectal Cancer: A Retrospective Study
- Incretin-based investigational therapies for the treatment of MASLD/MASH
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population
- Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
- Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis
- Evaluation of the role of body mass index (BMI) in the association between dietary inflammatory index and non-alcoholic fatty liver diseases: a letter to editor
- Fucoidan from Apostichopus japonicus ameliorates alcoholic liver disease by regulating gut-liver axis homeostasis
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- Inflammatory liver diseases and susceptibility to sepsis
- Fibroblast growth factor 19 alters bile acids to induce dysbiosis in mice with alcohol-induced liver disease
- Fibroblast growth factor 19 alters bile acids to induce dysbiosis in mice with alcohol-induced liver disease
- Correlation between Serum Levels of Nitric Oxide and Adropin and Erectile Dysfunction in Males with Nonalcoholic Fatty Liver Disease: An Observational Study
- A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
Evidence Blueprint
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
🌐 365 Days
VR Related Evidence Matrix
- Significant gut microbiota related to patterns of drinking and alcohol relapse in patients with alcoholic hepatitis undergoing stool transplant or corticosteroid therapy
- Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review
- A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis
- Critical care management of acute liver failure
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice
- Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD
- Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology
- How non-alcoholic fatty liver disease and cirrhosis affect the heart
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- Non-alcoholic fatty liver disease in patients with type 2 diabetes: diagnostic and therapeutic considerations
- Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
- Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes
- Occult liver disease: a multinational perspective
- Reply to Letter to the Editor regarding "Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis"
- Using race as a social construct when looking at differences in racial associations between non‑alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter]
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Role of serum endotoxin, FGF19, TLR2, TNF-α, IL-12 and IL-10 in NAFLD-associated T2DM pathogenesis: Insights into Th1 bias and protective mechanisms
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment
- Medium- and long-chain triglyceride propofol activates PI3K/AKT pathway and inhibits non-alcoholic fatty liver disease by inhibiting lipid accumulation
- Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease
- Towards precision medicine in non-alcoholic fatty liver disease
- Biomarkers of liver diseases
- Therapeutic potential of oleanolic acid in liver diseases
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies
- Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
- Alcohol as a health risk: new recommendations for dealing with alcohol
- Liver health and the interplay between obesity, alcohol and bariatric surgery
- The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review
- Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia
- Spatial genomics: mapping human steatotic liver disease
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD)
- Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies
- Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
- The significance of omega-3 fatty acids in the treatment of non-alcoholic fatty liver disease
- Mulberry fruit repairs alcoholic liver injury by modulating lipid metabolism and the expression of miR-155 and PPARα in rats
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Seroprevalence of hepatitis E virus in patients with chronic liver disease
- Fatty liver disease's renaming impacts on drug clinical trials
- Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
- Preventive hepatology at AIIMS Rishikesh: Delivering comprehensive and integrated care for liver diseases in Northern state of India
- Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Endohepatology: The endoscopic armamentarium in the hand of the hepatologist
- DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease
- Impacts of gut microbiota alteration on age-related chronic liver diseases
- Hormone action and liver disease, a complex interplay
- New Insights into Nutrition and Gut-Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease
- Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats